I kliniske studier i en pædiatrisk population med børn i alderen 2 til 12 år, var de almindelige bivirkninger, rapporteret hyppigere end ved placebo, hovedpine (2, 7%), nervøsitet (2, 3%) og træthed (1%).
In clinical trials in a paediatric population children aged 2 through 12 years, common adverse reactions reported in excess of placebo were headache (2.7%), nervousness (2.3%), and fatigue (1%).